Concepedia
Statistics
Publications
5
Citations
401
H-Index
Active since
2005
Affiliations
Mount Vernon Cancer Centre(Current)
Churchill Hospital
Cancer Research UK
University College London
L. Poupard is an author at Mount Vernon Cancer Centre specializing in oncology, pharmacology, and cancer pharmacology.
Publications per year
2005–2011
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer
Martin Zweifel, Gordon C. Jayson, N.S. Reed et al. · Annals of Oncology · 2011 · 161 citations
Medicine, Oncology, Pharmacology +16
A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer
Gordon Rustin, Gavin Shreeves, Paul Nathan et al. · British Journal of Cancer · 2010 · 130 citations · Full text
Medicine, Oncology, Pharmacology +17
A Phase I Trial of Radioimmunotherapy with 131I-A5B7 Anti-CEA Antibody in Combination with Combretastatin-A4-Phosphate in Advanced Gastrointestinal Carcinomas
Tim Meyer, Andrew Gaya, Gairin Dancey et al. · Clinical Cancer Research · 2009 · 77 citations
Combretastatin A-4 phosphate (CA4P) carboplatin and paclitaxel in patients with platinum-resistant ovarian cancer: Final phase II trial results
Martin Zweifel, Gordon C. Jayson, Nicholas S. Reed et al. · Journal of Clinical Oncology · 2009 · 18 citations
A phase I study of BIBF 1120, an orally active triple angiokinase inhibitor (VEGFR, PDGFR, FGFR) in patients with advanced solid malignancies
C. P. Lee, Gerhardt Attard, L. Poupard et al. · Journal of Clinical Oncology · 2005 · 15 citations
Pharmacy, Oncology, Pharmacology +15
1–5 of 5